MedDataX Logo

Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder

NCT ID: NCT01483339

Last Updated: 2017-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive-Compulsive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Metacognitive Therapy

Group Type EXPERIMENTAL

Metacognitive Therapy

Intervention Type BEHAVIORAL

Metacognitive Therapy for OCD according to Wells (1997)

Exposure and Response Prevention

Group Type EXPERIMENTAL

Exposure and Response Prevention

Intervention Type BEHAVIORAL

Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Metacognitive Therapy

Metacognitive Therapy for OCD according to Wells (1997)

Intervention Type BEHAVIORAL

Exposure and Response Prevention

Exposure and Response Prevention for OCD according to Kozak \& Foa (1997)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary diagnosis: obsessive-compulsive disorder
* German-speaking
* Agreeing to participate, verified by completion of informed consent

Exclusion Criteria

* Current or past diagnosis of substance dependence, psychosis, neurological conditions
* Mental retardation
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Psychotherapie-Ambulanz Marburg e.V.

OTHER

Sponsor Role collaborator

Philipps University Marburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Julia Anna Glombiewski

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cornelia Exner, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University of Leipzig

Winfried Rief, Prof. Dr.

Role: STUDY_DIRECTOR

Philipps University Marburg, Department of Clinical Psychology and Psychotherapy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Philipps Univerity Marburg, Department of Clinical Psychology and Psychotherapy

Marburg, Hesse, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Related Links

Access external resources that provide additional context or updates about the study.

http://www.uni-marburg.de/fb04/ag-klin/pam

Related Info

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MCT_OCD_2011

Identifier Type: -

Identifier Source: org_study_id